Year archive

AstraZeneca PLC — 2021 filings

All 318 regulatory filings released by AstraZeneca PLC (AZN) in 2021, sourced directly from the official regulator.

318 Filings

2021 Period

2021 filings (318)

Filing	Released	Lang
ASTRAZENECA AND IONIS CLOSE EPLONTERSEN DEAL Foreign Filer Report	2021-12-29	English
AstraZeneca and Ionis close eplontersen deal M&A Activity	2021-12-29	English
ULTOMIRIS ACCEPTED FOR FDA PRIORITY REVIEW FOR GMG Foreign Filer Report	2021-12-21	English
Ultomiris accepted for FDA Priority Review for gMG Regulatory Filings	2021-12-21	English
TEZSPIRE APPROVED IN THE US FOR SEVERE ASTHMA Foreign Filer Report	2021-12-20	English
SAPHNELO RECOMMENDED FOR EU APPROVAL FOR SLE Foreign Filer Report	2021-12-20	English
Tezspire approved in the US for severe asthma Regulatory Filings	2021-12-20	English
Saphnelo recommended for EU approval for SLE Regulatory Filings	2021-12-20	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-12-15	English
Director/PDMR Shareholding Director's Dealing	2021-12-15	English
EVUSHELD US FDA EUA Foreign Filer Report	2021-12-09	English
Evusheld US FDA EUA Regulatory Filings	2021-12-09	English
ASTRAZENECA, IONIS TO COLLABORATE ON EPLONTERSEN Foreign Filer Report	2021-12-07	English
AstraZeneca, Ionis to collaborate on eplontersen Regulatory Filings	2021-12-07	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2021-12-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-12-01	English
Block listing Interim Review Regulatory Filings	2021-12-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-12-01	English
LYNPARZA GRANTED FDA PRIORITY REVIEW FOR OLYMPIA Foreign Filer Report	2021-11-30	English
Lynparza granted FDA Priority Review for OlympiA Regulatory Filings	2021-11-30	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-11-15	English
Director/PDMR Shareholding Director's Dealing	2021-11-15	English
AZN: YEAR TO DATE AND Q3 2021 RESULTS Foreign Filer Report	2021-11-12	English
AZN: Year to date and Q3 2021 results Earnings Release 9M 2021	2021-11-12	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-11-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-11-01	English
ASTRAZENECA TO TRANSFER RIGHTS TO EKLIRA, DUAKLIR Foreign Filer Report	2021-11-01	English
AstraZeneca to transfer rights to Eklira, Duaklir Regulatory Filings	2021-11-01	English
IMFINZI IMPROVED SURVIVAL IN BILIARY TRACT CANCER Foreign Filer Report	2021-10-25	English
Imfinzi improved survival in biliary tract cancer Earnings Release Q4 2021	2021-10-25	English
AZ RECOMMENDS ADS HOLDERS REJECT MINI-TENDER OFFER Foreign Filer Report	2021-10-18	English
AZ recommends ADS holders reject mini-tender offer Legal Proceedings Report	2021-10-18	English
IMFINZI & TREMELIMUMAB IMPROVED OS IN LIVER CANCER Foreign Filer Report	2021-10-15	English
Imfinzi & tremelimumab improved OS in liver cancer Regulatory Filings	2021-10-15	English
AZD7442 PHIII TRIAL POSITIVE IN COVID OUTPATIENTS Foreign Filer Report	2021-10-12	English
AZD7442 PhIII trial positive in COVID outpatients Regulatory Filings	2021-10-11	English
ENHERTU GRANTED BTD FOR BREAST CANCER Foreign Filer Report	2021-10-04	English
Enhertu granted BTD for breast cancer Regulatory Filings	2021-10-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-10-01	English
Total Voting Rights Regulatory Filings	2021-10-01	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-09-30	English
Director/PDMR Shareholding Director's Dealing	2021-09-30	English
ASTRAZENECA TO FULLY ACQUIRE CAELUM BIOSCIENCES Foreign Filer Report	2021-09-29	English
AstraZeneca to fully acquire Caelum Biosciences M&A Activity	2021-09-29	English
SAPHNELO APPROVED IN JAPAN FOR SLE Foreign Filer Report	2021-09-28	English
Saphnelo approved in Japan for SLE Regulatory Filings	2021-09-28	English
LYNPARZA PROPEL TRIAL MEETS PRIMARY ENDPOINT Foreign Filer Report	2021-09-24	English
Lynparza PROpel trial meets primary endpoint Regulatory Filings	2021-09-24	English
BOARD COMMITTEE CHANGE Foreign Filer Report	2021-09-23	English
NEW SUSTAINABILITY COMMITTEE OF THE BOARD Foreign Filer Report	2021-09-23	English
New Sustainability Committee of the Board Environmental & Social Information	2021-09-23	English
Board Committee Change Board/Management Information	2021-09-23	English
ASTRAZENECA $360M IRISH MANUFACTURING INVESTMENT Foreign Filer Report	2021-09-21	English
AstraZeneca $360m Irish manufacturing investment Environmental & Social Information	2021-09-21	English
ENHERTU REDUCED RISK OF DISEASE PROGRESSION BY 72% Foreign Filer Report	2021-09-20	English
Enhertu reduced risk of disease progression by 72% Earnings Release Q3 2021	2021-09-20	English
IMFINZI IMPROVES SURVIVAL IN NSCLC IN POSEIDON Foreign Filer Report	2021-09-09	English
Imfinzi improves survival in NSCLC in POSEIDON Regulatory Filings	2021-09-09	English
FIXED-DOSE COMBINATION OF ALBUTEROL AND BUDESONIDE (PT027) DEMONSTRATED SIGNIFIC Foreign Filer Report	2021-09-09	English
PT027 PhIII asthma trials met primary endpoints Regulatory Filings	2021-09-09	English
ULTOMIRIS APPROVED IN EU FOR CHILDREN WITH PNH Foreign Filer Report	2021-09-03	English
Ultomiris approved in EU for children with PNH Regulatory Filings	2021-09-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-09-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-09-01	English
FORXIGA APPROVED IN JAPAN FOR CKD Foreign Filer Report	2021-08-26	English
ALXN1840 WILSON PHASE III MET PRIMARY ENDPOINT Foreign Filer Report	2021-08-26	English
Forxiga approved in Japan for CKD Regulatory Filings	2021-08-26	English
ALXN1840 Wilson Phase III met primary endpoint Regulatory Filings	2021-08-26	English
UPDATE ON ULTOMIRIS PHASE III ALS TRIAL Foreign Filer Report	2021-08-20	English
AZD7442 PROPHYLAXIS TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2021-08-20	English
Update on Ultomiris Phase III ALS trial Regulatory Filings	2021-08-20	English
AZD7442 prophylaxis trial met primary endpoint Regulatory Filings	2021-08-20	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-08-16	English
Director/PDMR Shareholding Director's Dealing	2021-08-16	English
UPDATE ON US REVIEW OF ROXADUSTAT Foreign Filer Report	2021-08-11	English
Update on US review of roxadustat Legal Proceedings Report	2021-08-11	English
FORXIGA APPROVED IN THE EU FOR CKD Foreign Filer Report	2021-08-09	English
ENHERTU HEAD-TO-HEAD TRIAL MEETS PRIMARY ENDPOINT Foreign Filer Report	2021-08-09	English
Forxiga approved in the EU for CKD Earnings Release Q3 2021	2021-08-09	English
Enhertu head-to-head trial meets primary endpoint Regulatory Filings	2021-08-09	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-08-02	English
Total Voting Rights Regulatory Filings	2021-08-02	English
SAPHNELO APPROVED IN THE US FOR SLE Foreign Filer Report	2021-08-02	English
Saphnelo approved in the US for SLE Regulatory Filings	2021-08-02	English
FORM 6-K/A Foreign Filer Report	2021-07-30	English
FORM 6-K Foreign Filer Report	2021-07-30	English
AZN: H1 2021 Results Earnings Release H1 2021	2021-07-29	English
SC 13G Major Shareholding Notification	2021-07-27	English
ULTOMIRIS RECOMMENDED IN EU FOR CHILDREN WITH PNH Foreign Filer Report	2021-07-26	English
Ultomiris recommended in EU for children with PNH Regulatory Filings	2021-07-26	English
DIRECTORATE CHANGE Foreign Filer Report	2021-07-22	English
Directorate Change Board/Management Information	2021-07-22	English
FORM 6-K Foreign Filer Report	2021-07-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-07-21	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-07-21	English
Director/PDMR Shareholding Director's Dealing	2021-07-21	English
Total Voting Rights Regulatory Filings	2021-07-21	English
ACQUISITION OF ALEXION COMPLETED Foreign Filer Report	2021-07-21	English
Acquisition of Alexion completed Delisting Announcement	2021-07-21	English
REGISTRATION OF AMERICAN DEPOSITAR RECEIPT SHARES Regulatory Filings	2021-07-19	English
IMFINZI APPROVED IN CHINA FOR EXTENSIVE-STAGE SCLC Foreign Filer Report	2021-07-19	English
Imfinzi approved in China for extensive-stage SCLC Regulatory Filings	2021-07-19	English
STATUS ON US FDA ADVISORY COMMITTEE FOR ROXADUSTAT Foreign Filer Report	2021-07-16	English
Status on US FDA Advisory Committee for roxadustat Legal Proceedings Report	2021-07-16	English
ASTRAZENECA-ALEXION TRANSACTION CLEARED IN THE UK Foreign Filer Report	2021-07-14	English
AstraZeneca-Alexion transaction cleared in the UK Regulatory Filings	2021-07-14	English
425 Filing Regulatory Filings	2021-07-14	English
425 Filing Regulatory Filings	2021-07-14	English
TEZEPELUMAB GRANTED FDA PRIORITY REVIEW FOR ASTHMA Foreign Filer Report	2021-07-08	English
Tezepelumab granted FDA Priority Review for asthma Regulatory Filings	2021-07-08	English
ASTRAZENECA-ALEXION TRANSACTION CLEARED IN THE EU Foreign Filer Report	2021-07-06	English
AstraZeneca-Alexion transaction cleared in the EU Regulatory Filings	2021-07-06	English
425 Filing Regulatory Filings	2021-07-06	English
425 Filing Regulatory Filings	2021-07-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-07-01	English
Total Voting Rights Regulatory Filings	2021-07-01	English
425 Filing Regulatory Filings	2021-06-30	English
FORM 11-K Regulatory Filings	2021-06-29	English
FORXIGA RECOMMENDED IN EU FOR PATIENTS WITH CKD Foreign Filer Report	2021-06-28	English
NIRSEVIMAB PHII/III TRIAL CONFIRMS SAFETY PROFILE Foreign Filer Report	2021-06-28	English
Forxiga recommended in EU for patients with CKD Regulatory Filings	2021-06-28	English
Nirsevimab PhII/III trial confirms safety profile Regulatory Filings	2021-06-28	English
LYNPARZA APPROVED IN CHINA FOR PROSTATE CANCER Foreign Filer Report	2021-06-24	English
Lynparza approved in China for prostate cancer Regulatory Filings	2021-06-24	English
ORPATHYS APPROVED IN CHINA FOR LUNG CANCER Foreign Filer Report	2021-06-23	English
Orpathys approved in China for lung cancer Regulatory Filings	2021-06-23	English
KOSELUGO APPROVED IN THE EU FOR CHILDREN WITH NF1 Foreign Filer Report	2021-06-22	English
Koselugo approved in the EU for children with NF1 Regulatory Filings	2021-06-22	English
UPDATE ON AZD7442 STORM CHASER TRIAL Foreign Filer Report	2021-06-15	English
Update on AZD7442 STORM CHASER trial Regulatory Filings	2021-06-15	English
CALQUENCE HEAD-TO-HEAD RESULTS VERSUS IBRUTINIB Foreign Filer Report	2021-06-07	English
Calquence head-to-head results versus ibrutinib Earnings Release Q2 2021	2021-06-07	English
LYNPARZA REDUCED RECURRENCE RISK IN BREAST CANCER Foreign Filer Report	2021-06-04	English
ASTRAZENECA APPOINTS NEW CHIEF FINANCIAL OFFICER Foreign Filer Report	2021-06-04	English
Lynparza reduced recurrence risk in breast cancer Regulatory Filings	2021-06-04	English
AstraZeneca appoints new Chief Financial Officer Regulatory Filings	2021-06-04	English
425 Filing Regulatory Filings	2021-06-04	English
425 Filing Regulatory Filings	2021-06-04	English
Issuer Document Capital/Financing Update	2021-06-03	English
Regulatory Filings 2021 Regulatory Filings	2021-06-03	English
PUBLICATION OF FINAL TERMS Foreign Filer Report	2021-06-02	English
Publication of Final Terms for €800m bond offering Capital/Financing Update	2021-06-02	English
Publication of Final Terms Capital/Financing Update	2021-06-02	English
8-A12B Regulatory Filings	2021-06-01	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2021-06-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-06-01	English
Block listing Interim Review Share Issue/Capital Change	2021-06-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-06-01	English
FORM 6-K Foreign Filer Report	2021-05-28	English
TAGRISSOAPPROVED IN THE EU FOR THE ADJUVANT TREATMENT OFPATIENTS WITH EARLY-STAG Foreign Filer Report	2021-05-28	English
Tagrisso approved in EU in early lung cancer Regulatory Filings	2021-05-28	English
424B2 Prospectus	2021-05-27	English
Second Price Monitoring Extn Regulatory Filings	2021-05-27	English
Price Monitoring Extension Regulatory Filings	2021-05-27	English
ASTRAZENECA PRICES A EUR800M BOND OFFERING Foreign Filer Report	2021-05-27	English
AstraZeneca prices a EUR800m bond offering Capital/Financing Update	2021-05-27	English
425 Filing Regulatory Filings	2021-05-27	English
ASTRAZENECA PRICES A $7BN BOND OFFERING Foreign Filer Report	2021-05-26	English
FORM 6-K Foreign Filer Report	2021-05-26	English
FWP Regulatory Filings	2021-05-26	English
FWP Regulatory Filings	2021-05-26	English
AstraZeneca prices a $7bn bond offering Capital/Financing Update	2021-05-26	English
AstraZeneca PLC;AstraZeneca Finance LLC - Base prospectus (debt) Regulatory Filings	2021-05-25	English
EMTN PROGRAMME UPDATE - PUBLICATION OF PROSPECTUS Foreign Filer Report	2021-05-25	English
EMTN update: publication of Prospectus Regulatory Filings	2021-05-25	English
EMTN programme update - publication of Prospectus Regulatory Filings	2021-05-25	English
424B2 Prospectus	2021-05-24	English
F-3ASR Regulatory Filings	2021-05-24	English
FORM 6-K Foreign Filer Report	2021-05-24	English
425 Filing Regulatory Filings	2021-05-24	English
ASTRAZENECA COVID-19 VACCINE VAXZEVRIA AUTHORISED FOR EMERGENCY USE IN JAPAN Foreign Filer Report	2021-05-21	English
Vaxzevria COVID-19 vaccine approved in Japan Regulatory Filings	2021-05-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-05-18	English
Director/PDMR Shareholding Director's Dealing	2021-05-18	English
Special Business Approved at General Meeting AGM Information	2021-05-11	English
RESULT OF AGM Foreign Filer Report	2021-05-11	English
Special Business Approved at AGM AGM Information	2021-05-11	English
SHAREHOLDERS VOTE IN FAVOUR OF ALEXION ACQUISITION Foreign Filer Report	2021-05-11	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2021-05-11	English
Shareholders vote in favour of Alexion acquisition Regulatory Filings	2021-05-11	English
IMFINZI + TREMELIMUMAB SHOWED SURVIVAL IN POSEIDON Foreign Filer Report	2021-05-07	English
Imfinzi + tremelimumab showed survival in POSEIDON Regulatory Filings	2021-05-07	English
425 Filing Regulatory Filings	2021-05-07	English
425 Filing Regulatory Filings	2021-05-06	English
425 Filing Regulatory Filings	2021-05-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-05-04	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-05-04	English
FARXIGA APPROVED IN THE US FOR CKD Foreign Filer Report	2021-05-04	English
Farxiga approved in the US for CKD Regulatory Filings	2021-05-04	English
AZN: FIRST QUARTER 2021 RESULTS Foreign Filer Report	2021-04-30	English
AZN: First quarter 2021 results Earnings Release Q1 2021	2021-04-30	English
425 Filing Regulatory Filings	2021-04-30	English
425 Filing Regulatory Filings	2021-04-30	English
425 Filing Regulatory Filings	2021-04-30	English
425 Filing Regulatory Filings	2021-04-29	English
NIRSEVIMAB PHASE III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2021-04-26	English
TAGRISSO ADJUVANT RECEIVES POSITIVE CHMP OPINION Foreign Filer Report	2021-04-26	English
SELUMETINIB RECOMMENDED FOR EU APPROVAL IN NF1 Foreign Filer Report	2021-04-26	English
Selumetinib recommended for EU approval in NF1 Regulatory Filings	2021-04-26	English
Tagrisso adjuvant receives positive CHMP opinion Regulatory Filings	2021-04-26	English
Nirsevimab Phase III trial met primary endpoint Regulatory Filings	2021-04-26	English
US CLEARANCE OF PROPOSED ACQUISITION OF ALEXION Foreign Filer Report	2021-04-16	English
US clearance of proposed acquisition of Alexion M&A Activity	2021-04-16	English
425 Filing Regulatory Filings	2021-04-16	English
425 Filing Regulatory Filings	2021-04-16	English
TAGRISSO APPROVED IN CHINA IN EARLY LUNG CANCER Foreign Filer Report	2021-04-14	English
Tagrisso approved in China in early lung cancer Legal Proceedings Report	2021-04-14	English
Regulatory Filings 2021 Regulatory Filings	2021-04-13	English
424B3 Prospectus	2021-04-12	English
FORM 6-K Foreign Filer Report	2021-04-12	English
CIRCULAR AND NOTICE OF GENERAL MEETING Foreign Filer Report	2021-04-12	English
Proxy Form - General Meeting Proxy Solicitation & Information Statement	2021-04-12	English
Circular to Shareholders and Notice of General Meeting Proxy Solicitation & Information Statement	2021-04-12	English
Circular and notice of general meeting AGM Information	2021-04-12	English
UPDATE ON FARXIGA COVID-19 DARE-19 PHASE III TRIAL Foreign Filer Report	2021-04-12	English
Update on Farxiga COVID-19 DARE-19 Phase III trial Regulatory Filings	2021-04-12	English
425 Filing Regulatory Filings	2021-04-12	English
425 Filing Regulatory Filings	2021-04-12	English
F-4/A Regulatory Filings	2021-04-09	English
Regulatory Filings 2021 Regulatory Filings	2021-04-08	English
SC 13G Major Shareholding Notification	2021-04-07	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-04-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-04-01	English
425 Filing Regulatory Filings	2021-04-01	English
425 Filing Regulatory Filings	2021-04-01	English
425 Filing Regulatory Filings	2021-04-01	English
NOTICE OF AGM Foreign Filer Report	2021-03-30	English
Proxy Form AGM Information	2021-03-30	English
Notice of AGM AGM Information	2021-03-30	English
FORM 6-K Foreign Filer Report	2021-03-30	English
Notice of AGM AGM Information	2021-03-30	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-03-25	English
AZD1222 US PH3 PRIMARY ANALYSIS CONFIRMS EFFICACY Foreign Filer Report	2021-03-25	English
Director/PDMR Shareholding Director's Dealing	2021-03-25	English
AZD1222 US Ph3 primary analysis confirms efficacy Regulatory Filings	2021-03-25	English
ASTRAZENECA US VACCINE TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2021-03-22	English
AstraZeneca US vaccine trial met primary endpoint Earnings Release Q1 2021	2021-03-22	English
4 Director's Dealing	2021-03-16	English
DIVESTMENT OF VIELA SHAREHOLDING COMPLETED Foreign Filer Report	2021-03-16	English
US SUPPLY AGREEMENT FOR ADDITIONAL AZD7442 DOSES Foreign Filer Report	2021-03-16	English
Divestment of Viela shareholding completed M&A Activity	2021-03-16	English
US supply agreement for additional AZD7442 doses Regulatory Filings	2021-03-16	English
425 Filing Regulatory Filings	2021-03-12	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-03-09	English
Director/PDMR Shareholding Remuneration Information	2021-03-09	English
DESIGNATION OF EU HOME MEMBER STATE FOR EU SECURITIES REGULATION PURPOSES Foreign Filer Report	2021-03-04	English
Designation of EU home member state Regulatory Filings	2021-03-04	English
US COURT DECISION FAVOURS SYMBICORT PATENTS Foreign Filer Report	2021-03-03	English
US court decision favours Symbicort patents Regulatory Filings	2021-03-03	English
FURTHER UPDATE ON US REGULATORY REVIEW OF ROXADUSTAT IN ANAEMIA OF CHRONIC KIDNE Foreign Filer Report	2021-03-02	English
Further update on roxadustat US regulatory review Legal Proceedings Report	2021-03-02	English
Regulatory Filings 2021 Regulatory Filings	2021-03-01	English
TRANSPARENCY DIRECTIVE VOTING RIGHTS AND CAPITAL Foreign Filer Report	2021-03-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-03-01	English
425 Filing Regulatory Filings	2021-02-26	English
425 Filing Regulatory Filings	2021-02-25	English
VOLUNTARY WITHDRAWAL OF IMFINZI INDICATION IN ADVANCED BLADDER CANCER IN THE US Foreign Filer Report	2021-02-22	English
Voluntary withdrawal Imfinzi US bladder indication Regulatory Filings	2021-02-22	English
F-4 Regulatory Filings	2021-02-19	English
LYNPARZA: IDMC RECOMMEND EARLY ANALYSIS OF OLYMPIA Foreign Filer Report	2021-02-17	English
Lynparza: IDMC recommend early analysis of OlympiA Regulatory Filings	2021-02-17	English
IRANNOTICE Regulatory Filings	2021-02-16	English
FILING OF FORM 20-F WITH SEC Foreign Filer Report	2021-02-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2021-02-16	English
ANNUAL FINANCIAL REPORT Foreign Filer Report	2021-02-16	English
Filing of Form 20-F with SEC Report Publication Announcement	2021-02-16	English
20-F Annual Report FY 2020	2021-02-16	English
Director/PDMR Shareholding Director's Dealing	2021-02-15	English
AstraZeneca PLC Annual Report and Form 20-F Information 2020 Annual Report FY 2020	2021-02-15	English
Annual Financial Report Report Publication Announcement	2021-02-15	English
425 Filing Regulatory Filings	2021-02-12	English
ASTRAZENECA NON-EXECUTIVE BOARD CHANGES Foreign Filer Report	2021-02-11	English
AZN: FULL-YEAR 2020 RESULTS Foreign Filer Report	2021-02-11	English
AstraZeneca Non-Executive Board changes Board/Management Information	2021-02-11	English
AZN: full-year 2020 results Earnings Release FY 2020	2021-02-11	English
425 Filing Regulatory Filings	2021-02-11	English
425 Filing Regulatory Filings	2021-02-11	English
425 Filing Regulatory Filings	2021-02-11	English
425 Filing Regulatory Filings	2021-02-11	English
SC 13G Major Shareholding Notification	2021-02-10	English
SC 13G/A Major Shareholding Notification	2021-02-10	English
DIVESTMENT OF CRESTOR IN EUROPE COMPLETED Foreign Filer Report	2021-02-10	English
Divestment of Crestor in Europe completed M&A Activity	2021-02-10	English
UPDATE ON KESTREL PHASE III TRIAL FOR IMFINZI Foreign Filer Report	2021-02-05	English
Update on KESTREL Phase III trial for Imfinzi Earnings Release Q1 2021	2021-02-05	English
FORXIGA APPROVED IN CHINA FOR HEART FAILURE Foreign Filer Report	2021-02-04	English
Forxiga approved in China for heart failure Regulatory Filings	2021-02-04	English
SEC SCHEDULE 13G Major Shareholding Notification	2021-02-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-02-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-02-01	English
ASTRAZENECA AGREES TO DIVEST VIELA SHAREHOLDING Foreign Filer Report	2021-02-01	English
AstraZeneca agrees to divest Viela shareholding M&A Activity	2021-02-01	English
COVID-19 VACCINE AUTHORISED FOR USE BY THE EU Foreign Filer Report	2021-02-01	English
COVID-19 vaccine authorised for use by the EU Regulatory Filings	2021-02-01	English
COVID-19 VACCINE RECEIVES POSITIVE OPINION IN EU Foreign Filer Report	2021-01-29	English
COVID-19 vaccine receives positive opinion in EU Regulatory Filings	2021-01-29	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-01-29	English
BLOCK LISTING APPLICATION Foreign Filer Report	2021-01-26	English
Block listing application Share Issue/Capital Change	2021-01-26	English
SYMBICORT APPROVED IN CHINA FOR MILD ASTHMA Foreign Filer Report	2021-01-26	English
Symbicort approved in China for mild asthma Regulatory Filings	2021-01-26	English
CALQUENCE APPROVED IN JAPAN FOR CLL Foreign Filer Report	2021-01-25	English
CALQUENCE MET PRIMARY EFFICACY ENDPOINT IN HEAD-TO-HEAD TRIAL AGAINST IBRUTINIB Foreign Filer Report	2021-01-25	English
Calquence approved in Japan for CLL Earnings Release Q1 2021	2021-01-25	English
Calquence met primary endpoint against ibrutinib Regulatory Filings	2021-01-25	English
ENHERTU APPROVED IN THE EU FOR BREAST CANCER Foreign Filer Report	2021-01-20	English
Enhertu approved in the EU for breast cancer Regulatory Filings	2021-01-20	English
ENHERTU APPROVED IN THE US FOR GASTRIC CANCER Foreign Filer Report	2021-01-19	English
Enhertu approved in the US for gastric cancer Regulatory Filings	2021-01-18	English
IMFINZI APPROVED IN THE EU FOR LESS-FREQUENT, FIXED- DOSE USE IN UNRESECTABLE NO Foreign Filer Report	2021-01-15	English
Imfinzi new dosing approved in EU Regulatory Filings	2021-01-15	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-01-13	English
FARXIGA GRANTED PRIORITY REVIEW IN THE US FOR THE TREATMENT OF PATIENTS WITH CHR Foreign Filer Report	2021-01-06	English
Farxiga granted US Priority Review for CKD Regulatory Filings	2021-01-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2021-01-04	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2021-01-04	English
ATACAND DIVESTMENT TO CHEPLAPHARM IN MORE THAN 70 COUNTRIES COMPLETED Foreign Filer Report	2021-01-04	English
Atacand divestment in over 70 countries completed M&A Activity	2021-01-04	English

Filings by year

2026 85 filings
2025 244 filings
2024 214 filings
2023 196 filings
2022 252 filings
2021 318 filings
2020 306 filings
2019 250 filings
2018 226 filings
2017 189 filings
2016 207 filings
2015 192 filings
2014 352 filings
2013 195 filings
2012 42 filings
2011 19 filings
2010 17 filings